Clinical Research on Type 2 Diabetes and Its Complications
The huge prevalence of type 2 diabetes is a leading human and economic concern worldwide. The diagnosis code of type 2 diabetes includes multiple clinical phenotypes showing different degrees of obesity, fat distribution patterns, types of dyslipidemia, and characteristics of insulin resistance synd...
محفوظ في:
| التنسيق: | Online |
|---|---|
| اللغة: | الإنجليزية |
| منشور في: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | ONIX_20231130_9783036594187_285 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1869528238213038080 |
|---|---|
| collection | Directory of Open Access Books |
| description | The huge prevalence of type 2 diabetes is a leading human and economic concern worldwide. The diagnosis code of type 2 diabetes includes multiple clinical phenotypes showing different degrees of obesity, fat distribution patterns, types of dyslipidemia, and characteristics of insulin resistance syndrome. In addition, subjects with type 2 diabetes could develop different clinical trajectories, with age being a critical factor in progression. The chronic complications of type 2 diabetes are a major cause of mortality and disability, and are ranked in the top places in western countries’ scores. The pathophysiological heterogeneity of type 2 diabetes is not captured by the current classifications and guidelines. The potential for diabetes progression and complications developing is different depending on the type 2 diabetes cluster, which is mostly regardless of the degree of glycemic control. However, the impact on quality and life expectancy with the current therapeutic approach is not always the same for every individual. Clinical research is the key to reducing the burden of diabetes. New basic, digital, and clinical approaches are obtaining useful knowledge and designing more individualized interventions to prevent, track, and treat diabetic complications. This Special Issue is a clear reflection of this methodological evolution. |
| format | Online |
| id | doab-20.500.12854ir-128833 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1288332024-03-31T13:09:57Z Clinical Research on Type 2 Diabetes and Its Complications Gómez-Peralta, Fernando dipeptidyl peptidase-4 inhibitor diabetes mellitus diabetic retinopathy progression machine learning diabetic sensorimotor polyneuropathy random forest prediction electrophysiology COVID-19 hyperglycemia glycemic control blood glucose monitoring telemedicine fibrosis NAFLD diabetes screening primary care secondary care glucose variability end-stage kidney disease Korean National Health Insurance Corporation microvascular complications cardiac autonomic neuropathy diabetic peripheral neuropathy diabetic nephropathy patient profiles non-alcoholic fatty liver disease non-alcoholic steatohepatitis NASH type 2 diabetes cardiovascular disease cardiovascular complications CVD complex intervention behaviour change intervention co-design continuity of care developing country Ethiopia patient participation patient transfer stroke outcome skin autofluorescence advanced glycation end products poststroke complications obesity and diabetes mellitus type 2 research hospitalization risk factors cardiovascular diseases type 2 gender type 2 diabetes mellitus bone fragility fracture risk bone structure bone quality cardiac fibrosis pulse wave velocity liraglutide body weight obesity hypoglycemia meta-analysis nephropathy urine albumin-creatinine ratio diabetes complications coronavirus infections hypoglycemic agents ambulatory care comorbidity glucagon-like peptide-1 receptor agonist HbA1c real-world evidence semaglutide SURE study pneumatosis intestinalis alpha-glucosidase inhibitors acarbose voglibose miglitol comorbidities concomitant drugs prednisone immunosuppressants n/a depression sex in-hospital mortality readmission empagliflozin SGLT-2 monocytes endothelial cells vascular dysfunction chemotaxis reactive oxygen species (ROS) glucose transport VEGFR-2 VEGFR-1 thema EDItEUR::M Medicine and Nursing The huge prevalence of type 2 diabetes is a leading human and economic concern worldwide. The diagnosis code of type 2 diabetes includes multiple clinical phenotypes showing different degrees of obesity, fat distribution patterns, types of dyslipidemia, and characteristics of insulin resistance syndrome. In addition, subjects with type 2 diabetes could develop different clinical trajectories, with age being a critical factor in progression. The chronic complications of type 2 diabetes are a major cause of mortality and disability, and are ranked in the top places in western countries’ scores. The pathophysiological heterogeneity of type 2 diabetes is not captured by the current classifications and guidelines. The potential for diabetes progression and complications developing is different depending on the type 2 diabetes cluster, which is mostly regardless of the degree of glycemic control. However, the impact on quality and life expectancy with the current therapeutic approach is not always the same for every individual. Clinical research is the key to reducing the burden of diabetes. New basic, digital, and clinical approaches are obtaining useful knowledge and designing more individualized interventions to prevent, track, and treat diabetic complications. This Special Issue is a clear reflection of this methodological evolution. 2023-11-30T20:56:58Z 2023-11-30T20:56:58Z 2023 book ONIX_20231130_9783036594187_285 9783036594187 9783036594194 https://directory.doabooks.org/handle/20.500.12854/128833 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/8303 https://mdpi.com/books/pdfview/book/8303 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-9419-4 10.3390/books978-3-0365-9419-4 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036594187 9783036594194 322 Basel open access |
| spellingShingle | dipeptidyl peptidase-4 inhibitor diabetes mellitus diabetic retinopathy progression machine learning diabetic sensorimotor polyneuropathy random forest prediction electrophysiology COVID-19 hyperglycemia glycemic control blood glucose monitoring telemedicine fibrosis NAFLD diabetes screening primary care secondary care glucose variability end-stage kidney disease Korean National Health Insurance Corporation microvascular complications cardiac autonomic neuropathy diabetic peripheral neuropathy diabetic nephropathy patient profiles non-alcoholic fatty liver disease non-alcoholic steatohepatitis NASH type 2 diabetes cardiovascular disease cardiovascular complications CVD complex intervention behaviour change intervention co-design continuity of care developing country Ethiopia patient participation patient transfer stroke outcome skin autofluorescence advanced glycation end products poststroke complications obesity and diabetes mellitus type 2 research hospitalization risk factors cardiovascular diseases type 2 gender type 2 diabetes mellitus bone fragility fracture risk bone structure bone quality cardiac fibrosis pulse wave velocity liraglutide body weight obesity hypoglycemia meta-analysis nephropathy urine albumin-creatinine ratio diabetes complications coronavirus infections hypoglycemic agents ambulatory care comorbidity glucagon-like peptide-1 receptor agonist HbA1c real-world evidence semaglutide SURE study pneumatosis intestinalis alpha-glucosidase inhibitors acarbose voglibose miglitol comorbidities concomitant drugs prednisone immunosuppressants n/a depression sex in-hospital mortality readmission empagliflozin SGLT-2 monocytes endothelial cells vascular dysfunction chemotaxis reactive oxygen species (ROS) glucose transport VEGFR-2 VEGFR-1 thema EDItEUR::M Medicine and Nursing Clinical Research on Type 2 Diabetes and Its Complications |
| title | Clinical Research on Type 2 Diabetes and Its Complications |
| title_full | Clinical Research on Type 2 Diabetes and Its Complications |
| title_fullStr | Clinical Research on Type 2 Diabetes and Its Complications |
| title_full_unstemmed | Clinical Research on Type 2 Diabetes and Its Complications |
| title_short | Clinical Research on Type 2 Diabetes and Its Complications |
| title_sort | clinical research on type 2 diabetes and its complications |
| topic | dipeptidyl peptidase-4 inhibitor diabetes mellitus diabetic retinopathy progression machine learning diabetic sensorimotor polyneuropathy random forest prediction electrophysiology COVID-19 hyperglycemia glycemic control blood glucose monitoring telemedicine fibrosis NAFLD diabetes screening primary care secondary care glucose variability end-stage kidney disease Korean National Health Insurance Corporation microvascular complications cardiac autonomic neuropathy diabetic peripheral neuropathy diabetic nephropathy patient profiles non-alcoholic fatty liver disease non-alcoholic steatohepatitis NASH type 2 diabetes cardiovascular disease cardiovascular complications CVD complex intervention behaviour change intervention co-design continuity of care developing country Ethiopia patient participation patient transfer stroke outcome skin autofluorescence advanced glycation end products poststroke complications obesity and diabetes mellitus type 2 research hospitalization risk factors cardiovascular diseases type 2 gender type 2 diabetes mellitus bone fragility fracture risk bone structure bone quality cardiac fibrosis pulse wave velocity liraglutide body weight obesity hypoglycemia meta-analysis nephropathy urine albumin-creatinine ratio diabetes complications coronavirus infections hypoglycemic agents ambulatory care comorbidity glucagon-like peptide-1 receptor agonist HbA1c real-world evidence semaglutide SURE study pneumatosis intestinalis alpha-glucosidase inhibitors acarbose voglibose miglitol comorbidities concomitant drugs prednisone immunosuppressants n/a depression sex in-hospital mortality readmission empagliflozin SGLT-2 monocytes endothelial cells vascular dysfunction chemotaxis reactive oxygen species (ROS) glucose transport VEGFR-2 VEGFR-1 thema EDItEUR::M Medicine and Nursing |
| topic_facet | dipeptidyl peptidase-4 inhibitor diabetes mellitus diabetic retinopathy progression machine learning diabetic sensorimotor polyneuropathy random forest prediction electrophysiology COVID-19 hyperglycemia glycemic control blood glucose monitoring telemedicine fibrosis NAFLD diabetes screening primary care secondary care glucose variability end-stage kidney disease Korean National Health Insurance Corporation microvascular complications cardiac autonomic neuropathy diabetic peripheral neuropathy diabetic nephropathy patient profiles non-alcoholic fatty liver disease non-alcoholic steatohepatitis NASH type 2 diabetes cardiovascular disease cardiovascular complications CVD complex intervention behaviour change intervention co-design continuity of care developing country Ethiopia patient participation patient transfer stroke outcome skin autofluorescence advanced glycation end products poststroke complications obesity and diabetes mellitus type 2 research hospitalization risk factors cardiovascular diseases type 2 gender type 2 diabetes mellitus bone fragility fracture risk bone structure bone quality cardiac fibrosis pulse wave velocity liraglutide body weight obesity hypoglycemia meta-analysis nephropathy urine albumin-creatinine ratio diabetes complications coronavirus infections hypoglycemic agents ambulatory care comorbidity glucagon-like peptide-1 receptor agonist HbA1c real-world evidence semaglutide SURE study pneumatosis intestinalis alpha-glucosidase inhibitors acarbose voglibose miglitol comorbidities concomitant drugs prednisone immunosuppressants n/a depression sex in-hospital mortality readmission empagliflozin SGLT-2 monocytes endothelial cells vascular dysfunction chemotaxis reactive oxygen species (ROS) glucose transport VEGFR-2 VEGFR-1 thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20231130_9783036594187_285 |